Company news
Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A (SSE:688393) news
Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A news releases on 6ix. Latest, Jan 1, 2025: Announcement on Voluntary Disclosure of HER2 Gene…
View Guangzhou Lbp Medicine Science & Technology Co., Ltd. Class A →
Press releases — page 2
Announcement on Voluntary Disclosure of HER2 Gene Detection Kit (Fluorescence in Situ Hybridization) Obtaining Registration Approval for Medical Device Changes
December 31, 2024
Announcement on the Resignation of Core Technical Personnel
December 20, 2024
Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
December 17, 2024
Announcement on Change of Sponsor Representative for Continuous Supervision
November 29, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 30, 2024
Announcement on Voluntary Disclosure of Qualifications Obtained by Company and Subsidiary from July to September 2024
October 11, 2024
Announcement on Expiration of Plan of Shareholding Reduction by Shareholder with Over 5% Shares and Results of Shareholding Reduction
September 30, 2024
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2024
August 29, 2024